Allianz Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-366,453
| Closed | -$27.6M | – | 1753 |
|
2022
Q2 | $27.6M | Buy |
366,453
+351,814
| +2,403% | +$26.5M | 0.03% | 565 |
|
2022
Q1 | $393K | Sell |
14,639
-46,615
| -76% | -$1.25M | ﹤0.01% | 1763 |
|
2021
Q4 | $2.93M | Sell |
61,254
-87,774
| -59% | -$4.2M | ﹤0.01% | 1294 |
|
2021
Q3 | $9.9M | Buy |
149,028
+58,814
| +65% | +$3.91M | 0.01% | 909 |
|
2021
Q2 | $7.04M | Buy |
90,214
+33,373
| +59% | +$2.6M | 0.01% | 909 |
|
2021
Q1 | $5.38M | Sell |
56,841
-10,001
| -15% | -$946K | 0.01% | 968 |
|
2020
Q4 | $8.14M | Buy |
66,842
+5,513
| +9% | +$672K | 0.01% | 888 |
|
2020
Q3 | $5.36M | Buy |
61,329
+4,649
| +8% | +$406K | 0.01% | 947 |
|
2020
Q2 | $3.66M | Sell |
56,680
-12,930
| -19% | -$835K | ﹤0.01% | 1095 |
|
2020
Q1 | $3.11M | Buy |
69,610
+24,883
| +56% | +$1.11M | ﹤0.01% | 1130 |
|
2019
Q4 | $2.79M | Sell |
44,727
-15,621
| -26% | -$973K | ﹤0.01% | 1366 |
|
2019
Q3 | $2.27M | Buy |
60,348
+47,290
| +362% | +$1.77M | ﹤0.01% | 1409 |
|
2019
Q2 | $531K | Buy |
+13,058
| New | +$531K | ﹤0.01% | 1904 |
|